Rocca

Infrastructure and Energy Alternatives, Inc. Announces the Addition of Michael Della Rocca to Board of Directors

Retrieved on: 
Monday, November 9, 2020
Service companies, Engineering organizations, WSP USA, Della Rocca, AECOM, Rocca, McKinsey & Company, Industries

Mr. Della Roccas appointment increases the size of IEAs Board of Directors to eight members.

Key Points: 
  • Mr. Della Roccas appointment increases the size of IEAs Board of Directors to eight members.
  • Most recently, Mr. Della Rocca was as a partner at McKinsey & Company, retiring in 2020 after a six-year tenure with the firm.
  • Before AECOM, Mr. Della Rocca held numerous executive management roles at Halcrow Holdings, STV, Raytheon and Parsons Brinckerhoff, now WSP USA.
  • Infrastructure and Energy Alternatives, Inc. is a leading infrastructure construction company with renewable energy and specialty civil expertise.

Tenaris’s Board of Directors Provides Full Support to its Chairman and Chief Executive Officer and two other Directors

Retrieved on: 
Friday, February 14, 2020
Techint, Companies, Government, Economy, Paolo Rocca, Tenaris, Gianfelice Rocca, Rocca, TS, Bonatti, Prosecutor

LUXEMBOURG, Feb. 14, 2020 (GLOBE NEWSWIRE) -- Tenaris S.A. (NYSE, Mexico: TS and MTA Italy: TEN) today issued the following statement:

Key Points: 
  • LUXEMBOURG, Feb. 14, 2020 (GLOBE NEWSWIRE) -- Tenaris S.A. (NYSE, Mexico: TS and MTA Italy: TEN) today issued the following statement:
    Tenaris has been advised that the Italian court overseeing the investigation into alleged improper payments made in Brazil for the supposed benefit of Confab Industrial S.A., a Brazilian subsidiary of the Company, has decided to move the case to trial.
  • The case involves Chairman and Chief Executive Officer Paolo Rocca and Board members Gianfelice Rocca and Roberto Bonatti, and the Companys controlling shareholder, San Faustin S.A.
  • The Companys outside counsel previously reviewed the Italian prosecutors investigative file and has informed the Board that neither that file nor this magistrates decision sets forth evidence of involvement by any of the three directors in the alleged wrongdoing.
  • Accordingly, the Board has concluded that no particular action is warranted at the present time, other than inviting the referred board members to continue discharging their respective responsibilities with the full support of the Board.

Interpace Biosciences Announces Addition to Board of Directors and Changes in Leadership

Retrieved on: 
Thursday, January 30, 2020
Rocca

PARSIPPANY, NJ, Jan. 30, 2020 (GLOBE NEWSWIRE) -- Interpace Biosciences , Inc. (NASDAQ: IDXG) (Interpace) a leader in enabling personalized medicine, is pleased to announce today that Ron Rocca, President & CEO of Exagen, Inc. (NASDAQ: XGN) has been appointed to the Interpace Board of Directors.

Key Points: 
  • PARSIPPANY, NJ, Jan. 30, 2020 (GLOBE NEWSWIRE) -- Interpace Biosciences , Inc. (NASDAQ: IDXG) (Interpace) a leader in enabling personalized medicine, is pleased to announce today that Ron Rocca, President & CEO of Exagen, Inc. (NASDAQ: XGN) has been appointed to the Interpace Board of Directors.
  • According to Steve Sullivan, Interpaces Chairman of the Board, We are very pleased to welcome Mr. Rocca to the Board of Interpace.
  • In addition, Interpace is announcing the hiring of Jeff Salzman as Vice President of Managed Care and Payer Relations.
  • Because of these and other risks, uncertainties and assumptions, undue reliance should not be placed on these forward-looking statements.